Title of article
Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden
Author/Authors
Denise R. Hirsch، نويسنده , , Katriina M. Mikkola، نويسنده , , Peter W. Marks، نويسنده , , Edward A. Fox، نويسنده , , David M. Dorfman، نويسنده , , Bruce M. Ewenstein، نويسنده , , Samuel Z. Goldhaber MD FACC، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1996
Pages
4
From page
1145
To page
1148
Abstract
Activated protein C resistance caused by factor V Leiden mutation is the most common inherited cause of an underlying predisposition to pulmonary embolism (PE) and deep venous thrombosis (DVT). We studied the frequency of the factor V Leiden mutation in 50 women who had PE and/or DVT during or after pregnancy or during oral contraceptive use. Ten (20%; 95% Cl 10% to 34%) of the 50 women were heterozygous for the mutation. First-trimester PE or DVT developed in 6 (60%; 95% Cl, 26% to 88%) of the 10 women with the mutation compared with 3 (8%; 95% Cl 2% to 20%) of 40 women without the mutation (p = 0.0009). These data indicate that the factor V Leiden mutation is an important risk factor for PE or DVT during pregnancy (especially the first trimester), after pregnancy, or during oral contraceptive use.
Journal title
American Heart Journal
Serial Year
1996
Journal title
American Heart Journal
Record number
526984
Link To Document